Outcomes | Estimate (95% CI) | p-value | |
---|---|---|---|
Progression-free survival | Hazard ratio | ||
Primary location (Others vs. Oropharynx) | 3.65 (1.77–7.52) | < 0.001 | |
T classification (from one unit to next) | 1.43 (1.09–1.89) | 0.011 | |
Treatment strategy (Inadequate vs. CCRT) | 2.28 (1.23–4.20) | 0.009 | |
Overall survival | |||
HPV status (Positive vs. Negative) | 0.29 (0.14–0.63) | 0.002 | |
Primary location (Oral cavity vs. Oropharynx) | 1.82 (1.22–2.71) | 0.003 | |
T classification (from one unit to next) | 1.30 (1.08–1.57) | 0.006 | |
N classification (from one unit to next) | 1.58 (1.20–2.08) | 0.001 | |
Treatment strategy (Inadequate vs. CCRT) | 2.31 (1.35–3.97) | 0.002 |